359 related articles for article (PubMed ID: 15795933)
21. Phospholipid transfer protein in hemodialysis patients.
Schlitt A; Heine GH; Jiang XC; Messow M; Blankenberg S; Rupprecht HJ; Ulrich C; Buerke M; Werdan K; Lackner KJ; Köhler H; Girndt M
Am J Nephrol; 2007; 27(2):138-43. PubMed ID: 17308375
[TBL] [Abstract][Full Text] [Related]
22. Structure and functions of human cerebrospinal fluid lipoproteins from individuals of different APOE genotypes.
Rebeck GW; Alonzo NC; Berezovska O; Harr SD; Knowles RB; Growdon JH; Hyman BT; Mendez AJ
Exp Neurol; 1998 Jan; 149(1):175-82. PubMed ID: 9454626
[TBL] [Abstract][Full Text] [Related]
23. Phospholipid transfer protein is present in human tear fluid.
Jauhiainen M; Setälä NL; Ehnholm C; Metso J; Tervo TM; Eriksson O; Holopainen JM
Biochemistry; 2005 Jun; 44(22):8111-6. PubMed ID: 15924430
[TBL] [Abstract][Full Text] [Related]
24. Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease.
Bales KR
Neuropharmacology; 2010; 59(4-5):295-302. PubMed ID: 20079752
[TBL] [Abstract][Full Text] [Related]
25. The endosomal trafficking of apolipoprotein E3 and E4 in cultured human brain neurons and astrocytes.
DeKroon RM; Armati PJ
Neurobiol Dis; 2001 Feb; 8(1):78-89. PubMed ID: 11162242
[TBL] [Abstract][Full Text] [Related]
26. Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
Ohrfelt A; Grognet P; Andreasen N; Wallin A; Vanmechelen E; Blennow K; Zetterberg H
Neurosci Lett; 2009 Feb; 450(3):332-5. PubMed ID: 19022350
[TBL] [Abstract][Full Text] [Related]
27. Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease.
Abe T; Tohgi H; Isobe C; Murata T; Sato C
J Neurosci Res; 2002 Nov; 70(3):447-50. PubMed ID: 12391605
[TBL] [Abstract][Full Text] [Related]
28. Cathepsin D-mediated proteolysis of apolipoprotein E: possible role in Alzheimer's disease.
Zhou W; Scott SA; Shelton SB; Crutcher KA
Neuroscience; 2006 Dec; 143(3):689-701. PubMed ID: 16997486
[TBL] [Abstract][Full Text] [Related]
29. Increased atherosclerotic lesions in apoE mice with plasma phospholipid transfer protein overexpression.
Yang XP; Yan D; Qiao C; Liu RJ; Chen JG; Li J; Schneider M; Lagrost L; Xiao X; Jiang XC
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1601-7. PubMed ID: 12855484
[TBL] [Abstract][Full Text] [Related]
30. High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease.
Schlitt A; Bickel C; Thumma P; Blankenberg S; Rupprecht HJ; Meyer J; Jiang XC
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1857-62. PubMed ID: 12947020
[TBL] [Abstract][Full Text] [Related]
31. Human plasma phospholipid transfer protein activity is decreased by acute hyperglycaemia: studies without and with hyperinsulinaemia in Type 1 diabetes mellitus.
Oomen PH; van Tol A; Hattori H; Smit AJ; Scheek LM; Dullaart RP
Diabet Med; 2005 Jun; 22(6):768-74. PubMed ID: 15910630
[TBL] [Abstract][Full Text] [Related]
32. Effect of apolipoprotein E (apoE) phenotype on the apoE content of CSF-HDL in children.
Hirayama S; Miida T; Obayashi K; Yamazaki F; Yamazaki-Sakurai M; Ito M; Saito Y; Hanyu O; Suzuki K; Aizawa Y
Clin Chim Acta; 2005 Jun; 356(1-2):110-6. PubMed ID: 15936307
[TBL] [Abstract][Full Text] [Related]
33. Converging pathways of chromogranin and amyloid metabolism in the brain.
Mattsson N; Johansson P; Hansson O; Wallin A; Johansson JO; Andreasson U; Andersen O; Haghighi S; Olsson M; Stridsberg M; Svensson J; Blennow K; Zetterberg H
J Alzheimers Dis; 2010; 20(4):1039-49. PubMed ID: 20413871
[TBL] [Abstract][Full Text] [Related]
34. Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxycholesterol in patients with cognitive disorders.
Shafaati M; Solomon A; Kivipelto M; Björkhem I; Leoni V
Neurosci Lett; 2007 Sep; 425(2):78-82. PubMed ID: 17822846
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein E in the brain and its role in Alzheimer's disease.
Poirier J
J Psychiatry Neurosci; 1996 Mar; 21(2):128-34. PubMed ID: 8820179
[TBL] [Abstract][Full Text] [Related]
36. Implication of apoE isoforms in cholesterol metabolism by primary rat hippocampal neurons and astrocytes.
Rapp A; Gmeiner B; Hüttinger M
Biochimie; 2006 May; 88(5):473-83. PubMed ID: 16376010
[TBL] [Abstract][Full Text] [Related]
37. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
[TBL] [Abstract][Full Text] [Related]
38. Increased acidic fibroblast growth factor concentrations in the serum and cerebrospinal fluid of patients with Alzheimer's disease.
Mashayekhi F; Hadavi M; Vaziri HR; Naji M
J Clin Neurosci; 2010 Mar; 17(3):357-9. PubMed ID: 20079650
[TBL] [Abstract][Full Text] [Related]
39. Neuropsychological and behavioural correlates of CSF biomarkers in dementia.
Engelborghs S; Maertens K; Vloeberghs E; Aerts T; Somers N; Mariën P; De Deyn PP
Neurochem Int; 2006 Mar; 48(4):286-95. PubMed ID: 16434124
[TBL] [Abstract][Full Text] [Related]
40. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
